Full Press Release Details
NEW BRUNSWICK, N.J. , Aug. 12, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15 th . Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Mathai Mammen , Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:30 a.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately 48-hrs after the live webcast.